We are live on ! Find out more
AURA icon

Aura Biosciences
AURA

106 hedge funds and large institutions have $319M invested in Aura Biosciences in 2025 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 25 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 25

15% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 13

2% more funds holding

Funds holding: 104 → 106 (+2)

1% more capital invested

Capital invested by funds: $317M → $319M (+$2.33M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

17.55% less ownership

Funds ownership: 100.69% → 83.14% (-18%)

Holders
106
Holders Change
+2
Holders Change %
+1.92%
% of All Funds
1.39%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
35
Reduced
25
Closed
13
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.7M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.14M
3
BlackRock
BlackRock
New York
+$1.98M
4
LCS
Levin Capital Strategies
New York
+$861K
5
Walleye Capital
Walleye Capital
New York
+$440K

Top Sellers

Rank Fund Capital Flow
1
SB
Samsara BioCapital
California
-$2.71M
2
Franklin Resources
Franklin Resources
California
-$928K
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$407K
4
HF
HRT Financial
New York
-$353K
5
RCM
Regency Capital Management
Hawaii
-$348K
Name Holding Trade Value Shares
Change 		Change in
Stake
BTI
101
Blue Trust Inc
Georgia
$531 – – –
PA
102
Parallel Advisors
California
$488 – – –
AF
103
Allworth Financial
California
$359 -$1.33K -203 -78%
Nisa Investment Advisors
104
Nisa Investment Advisors
Missouri
$222 – – –
RIL
105
Rothschild Investment LLC
Illinois
$216 -$262 -40 -53%
IA
106
IFP Advisors
Florida
$6 +$7 +1 New
HF
107
HRT Financial
New York
– -$353K -56,529 Closed
Susquehanna International Group
108
Susquehanna International Group
Pennsylvania
– -$329K -52,594 Closed
AI
109
Atria Investments
North Carolina
– -$190K -30,309 Closed
GFA
110
Gallagher Fiduciary Advisors
Illinois
– -$189K -30,239 Closed
AG
111
Ascent Group
Virginia
– -$87.4K -13,964 Closed
VOYA Investment Management
112
VOYA Investment Management
Georgia
– -$85K -13,582 Closed
Citadel Advisors
113
Citadel Advisors
Florida
– -$80.3K -12,831 Closed
ProShare Advisors
114
ProShare Advisors
Maryland
– -$62.6K -10,003 Closed
JG
115
Jain Global
New York
– -$62.6K -10,000 Closed
VCM
116
Versant Capital Management
Arizona
– -$4.13K -659 Closed
BIG
117
Brooklyn Investment Group
New York
– -$470 -75 Closed
1 2 3 4
5

AURA Hedge Fund Activity: Q3 2025 in Review

106 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q3 2025, worth a combined $319M — up 0.73% from $317M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AURA positions and 13 closed out — a net gain of 2 holders — while 35 added to existing stakes and 25 trimmed.

The largest buyer was Vanguard Group, adding an estimated $2.7M. The largest seller was Samsara BioCapital, cutting an estimated $2.71M.

  • 106 institutional investors held Aura Biosciences (AURA) as of Q3 2025, up from 104 in Q2 2025.
  • Funds reported $319M of Aura Biosciences stock for Q3 2025, up 0.73% quarter-over-quarter.
  • 15 funds opened new Aura Biosciences positions in Q3 2025 and 13 closed out, a net change of +2 holders.
  • The largest Aura Biosciences buyer in Q3 2025 was Vanguard Group, an estimated $2.7M added.
  • The largest Aura Biosciences seller in Q3 2025 was Samsara BioCapital, an estimated $2.71M sold.

Based on aggregated 13F filings for Q3 2025.